breast cancer detection News
-
Scion Acquires Soft Tissue Biopsy Product Line
June 15, 2012 – Newton, Massachusetts. Scion Medical Technologies, LLC (Scion), a company that manufactures and sells products in the general surgery area, announced today that it has acquired a suite of assets for soft tissue biopsy, including issued intellectual property for a novel approach in the field. Scion is completing the final stages of development of the product and plans to ...
-
Transpara breast AI reduces false positives and radiologists` workload in largest Danish screening programme
The team running the country's largest breast screening programme have shown that using Transpara breast AI further confirmed the enormous contribution of this technology to breast cancer detection: not only to reduce the number of false positives but also to reduce radiologists' workload by over 60%. In Copenhagen, the biannual breast screening programme for women aged from 50 to 69, has been ...
-
QView Medical Signs European Distribution Agreement to sell AI/QVCAD for Breast Cancer Detection
QView Medical and Traf Intercontinental announce a distribution agreement under which Traf International will sell QView Medical's QVCAD System to breast imaging clinics in Europe. QVCAD is the AI solution to assist the radiologist in detecting breast cancer in 3D Automated Breast Ultrasound images In this post-CoVid-19 environment, QView Medical searched for a more direct sales focus in ...
-
New Findings Show AI Software Improves Breast Cancer Detection and Physician Accuracy
A New York City based large volume private practice radiology group conducted a quality assurance review that included an 18 month software evaluation in the breast center comprised of nine (9) specialist radiologists using an FDA cleared artificial intelligence software by Koios Medical, Inc as a second opinion for analyzing and assessing lesions found during breast ultrasound examinations. ...
-
Women’s Health and AI, CureMetrix Joins Forces with AuntMinnie.com and AuntMinnieEurope.com for Virtual Conference
CureMetrix, Inc., a global healthcare technology company that delivers AI-driven software for radiology once again joins forces with AuntMinnie and AuntMinnieEurope, along with industry experts, for the AuntMinnie.com 2022 Virtual Conference - AI, Women’s Health, and More - to be held on March 30 and 31, 2022. Women want to know that the latest technology is supporting their healthcare ...
-
TeraRecon Appoints Sinan Batman CTO
Advanced visualization and AI leader TeraRecon today announced the appointment of Sinan Batman as Chief Technology Officer, responsible for developing next-gen, AI-based advanced visualization and clinical workflow application technologies. "Sinan shares our drive for better patient outcomes and value through out-of-the-box solutions for streamlined efficiency and effectiveness," said Romesh ...
-
Seno Medical and “Know Your Lemons” Highlight Importance of Education and Self-Exam for Early Breast Cancer Detection
A recent survey of women in the Netherlands found that 79 percent of respondents diagnosed with breast cancer noticed symptoms prior to being diagnosed. Seno Medical Instruments, Inc. (Seno Medical), a Texas-based medical imaging company developing breakthrough breast cancer diagnostic technology, teamed up with the Know Your Lemons campaign to conduct the survey in the Netherlands, which has ...
-
ScreenPoint Medical appoints new CEO
Following the success of the world's leading AI Breast Care system, Transpara®, now in use across the US and in 30 countries worldwide, ScreenPoint Medical, the company that developed Transpara, has appointed Mark Koeniguer as its new CEO to lead the next phase of growth and accelerate the company's international expansion. Koeniguer, who has extensive experience leading and growing ...
-
Rezolut and CureMetrix Embark on AI Innovation Partnership
Rezolut, LLC and CureMetrix, Inc. have launched a pilot program in the Greater New York City area with the aim of pairing advanced technology with operational excellence to improve breast cancer detection in women receiving routine screening mammograms. Rezolut, LLC is a national, emerging platform of diagnostic medical imaging services, serving patients across the United States with 23 ...
-
AMA recognizes Dedicated Breast CT by assigning 6 CPT Codes
On June 15th, 2020, the American Medical Association (AMA) granted 6 Category III CPT codes for the FDA PMA cleared dedicated breast CT imaging procedure. The newly assigned CPT codes in addition to the previous FDA PMA clearance process, formally introduces access to this new and advanced modality on January 1, 2021. The AMA technical subcommittee, comprised of prominent members of the ...
-
Perimeter Medical Imaging AI to Participate in Panel Discussion “Innovations in Breast Cancer Detection, Surgery and Treatment” at the Lytham Partners Summer 2021 Investor Conference
Perimeter Medical Imaging AI, Inc. (TSX-V: PINK)(OTC: PYNKF)(FSE:4PC) (“Perimeter” or the “Company”), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs, today announced that the Company's Chief Executive Officer, Jeremy Sobotta, will participate in a panel at the ...
-
Study published in BJC shows strong performance of Tethis’ liquid biopsy test in early stage breast cancer
Study Published in British Journal of Cancer Shows High Sensitivity and Specificity of Tethis’ Liquid Biopsy Platform in Early Stage Breast Cancer and the Identification of Circulating Tumor Cells Clusters for the First Time in Non-Metastatic Patients Tethis S.p.A announced the publication of a pilot study in early breast cancer showing the analytical performance of the novel SBS® ...
By Tethis S.p.A
-
QView Medical maintains leadership position in AI-powered breast cancer screening technology through alliance with GE Healthcare
QView Medical, a breast cancer detection pioneer and maker of the FDA-approved artificial intelligence (AI) software system for breast cancer screening, and GE Healthcare today announced that QView's QVCAD software can be launched on GE Healthcare's Invenia™ ABUS 2.0 (Automated Breast Ultrasound), which has an open platform technology that allows the integration of third-party AI tools for ...
-
A study with over 2,000 cancers missed by screening shows that Transpara AI can effectively help detect breast cancer earlier
ScreenPoint Medical's Transpara AI decision support system can help radiologists to identify potential breast cancers earlier and faster, according to a new study published in Radiology. The ground breaking evidence-based software is already in clinical use in over 30 countries including the USA, France, Germany and Spain. The incidence of breast cancer is increasing worldwide due to ...
-
4th Annual Pink at the Pump Campaign Raises Over $20,000 for Breast Cancer Research and Patient Support
This October Iowa drivers raised over $20,000 for breast cancer research and support services simply by choosing cleaner-burning Unleaded 88 during the 4th annual Pink at the Pump® campaign, co-sponsored by the Iowa Renewable Fuels Association (IRFA) and Iowa Corn Promotion Board (ICPM). Seventy-four retail stations donated three cents of every gallon of Unleaded 88 sold from Oct. 1 through ...
-
Kheiron Medical Technologies Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2022
Kheiron Medical Technologies has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2022. Kheiron has pioneered the development and deployment of artificial intelligence solutions to help radiologists detect breast cancer earlier, and the company is currently leveraging its existing technologies and expertise to expand into new cancer ...
-
Kheiron Medical Technologies Forms US Breast Medical Advisory Board; Appoints Three Leaders With Deep Track Record Advocating For Women’s Health
Kheiron Medical Technologies today announced the appointment of Dr. Wendy DeMartini, Dr. Elizabeth Morris, and Dr. Amy Patel to its US Breast Medical Advisory Board. These appointments reinforce Kheiron’s focus on bringing its artificial intelligence solutions to the US market to help radiologists detect breast cancer earlier. Kheiron is committed to assembling an inclusive advisory board ...
-
No nonsense steps to a better planet
Everyone's favorite brand is committed to taking "Steps to a Better Planet". Like your best friend, No nonsense is a brand that understands the importance of giving back. Socially and environmentally responsible, No nonsense makes a concerted effort each and every day to reduce its carbon footprint and to also give back to those in need. 95% of No nonsense products are "Made in the USA" in ...
-
Stanford University Partners with Kheiron Medical Technologies to Pioneer Use of AI in New Areas of Oncology
Kheiron Medical Technologies today announced its new collaboration with researchers at Stanford University to design functional proof-of-concept deep learning models to solve clinical problems in novel ways, starting with Non-Hodgkin’s Lymphoma (NHL). With the collaboration, Kheiron, which has pioneered the development and deployment of artificial intelligence solutions to help radiologists ...
-
ScreenPoint Medical`s Transpara AI reads over three million mammograms
Transpara, the world's leading artificial intelligence (AI) breast care software, has now reached a major new milestone, helping radiologists read over three million mammograms. Across the US, Transpara is providing hundreds of radiologists with a 'second pair' of eyes helping detect cancers earlier and reduce recall rates. Among the radiologists using this revolutionary AI breast care system, ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you